行情

RGEN

RGEN

Repligen Corp
NASDAQ

实时行情|Nasdaq Last Sale

81.68
-1.54
-1.85%
盘后: 81.68 0 0.00% 16:41 11/14 EST
开盘
82.86
昨收
83.22
最高
83.15
最低
81.64
成交量
32.30万
成交额
--
52周最高
99.25
52周最低
48.26
市值
42.52亿
市盈率(TTM)
165.92
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

RGEN 新闻

  • 美各州对谷歌反垄断调查将扩展到搜索和安卓业务
  • 新浪科技.2小时前
  • 阿里巴巴启动香港上市交易 或筹资120亿美元
  • 新浪财经.2小时前
  • 瑞银在新加坡被罚款1120万新元
  • 新浪财经.3小时前
  • 催收巨头湖南永雄上将于下周三在纽交所上市
  • 新浪财经-自媒体综合.3小时前

更多

所属板块

医疗设备、用品及经销
+0.19%
医疗设备和用品
+0.16%

热门股票

名称
价格
涨跌幅

RGEN 简况

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.
展开

Webull提供Repligen Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。